Atlas Trials

A Study of CM310 in Subjects With Moderate to Severe Asthma

Clinical trial NCT05761028 · RECRUITING

Trial details

NCT number
NCT05761028
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Moderate to Severe Asthma
Start date
2023-04-28
Primary completion
2032-05-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.